Related Experiment Video

Updated: Jun 12, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.3K

Sentinel lymph node biopsy may no longer be a critical component of melanoma management

Athanassios Kyrgidis1, Anthony J Dixon2, Michael Sladden3

  • 1Aristotle University of Thessaloniki, Thessaloniki, Greece.

Journal of the European Academy of Dermatology and Venereology : JEADV
|September 23, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

19.3K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

2.9K

Related Experiment Videos

Last Updated: Jun 12, 2025

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
05:52

Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy

Published on: August 19, 2021

11.3K
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

19.3K
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

2.9K

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K

Articles linked to this work by shared authors, journal, and citation graph.

International qualitative case studies of system-level approaches to promote the development, adoption, and implementation of artificial intelligence in healthcare.

Journal of the American Medical Informatics Association : JAMIA·2026

The Role of General Practitioners in Actinic Keratosis Management in Europe: A Dermato-Oncologists Initiative.

Journal of clinical medicine·2026

Effects of α-Synuclein on the Lipid Phenotype of SZ95 Human Sebocytes: A Preliminary Study in the Context of Parkinson's Disease.

Cells·2026

European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

A system-level analysis of challenges and strategies for scaling artificial intelligence in healthcare: A qualitative study of the NHS AI lab.

Digital health·2026

Prospective subtyping of head and neck basal cell carcinoma by dermoscopy and handheld RCM.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Management of chronic urticaria: Current status and future prospect.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Systemic treatment of cutaneous leishmaniasis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026

Five-year survival impact of adjuvant anti-PD-1 therapy in a nationwide cohort of stage III melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us